Mohammad Fatehi
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Multiscale computational analysis reveals enhanced allosteric modulation of Nav1.5 by dual binding of dapagliflozin and ertugliflozin.
Journal: Scientific reports
Published: September 12, 2025
The sodium/glucose cotransporter 2 inhibitor Empagliflozin inhibits long QT 3 late sodium currents in a mutation specific manner.
Journal: Journal of molecular and cellular cardiology
Published: June 28, 2024
Regulation of PKD2 channel function by TACAN.
Journal: The Journal of physiology
Published: November 01, 2022
Do Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure in Patients with Type 2 Diabetes?
Journal: Current diabetes reviews
Published: August 20, 2021
Vitamin D is an endogenous partial agonist of the transient receptor potential vanilloid 1 channel.
Journal: The Journal of physiology
Published: June 04, 2020
Androgen Therapy in Male Patients Suffering from Type 2 Diabetes: A Review of Benefits and Risks.
Journal: Current diabetes reviews
Published: May 24, 2018
Current Views on Dopaminergic Drugs Affecting Glucose Homeostasis.
Journal: Current diabetes reviews
Published: October 13, 2017
The mechano-sensitivity of cardiac ATP-sensitive potassium channels is mediated by intrinsic MgATPase activity.
Journal: Journal of molecular and cellular cardiology
Published: April 05, 2017
Molecular determinants of ATP-sensitive potassium channel MgATPase activity: diabetes risk variants and diazoxide sensitivity.
Journal: Bioscience reports
Published: June 01, 2015
Last Updated: 09/26/2026